Lancet Infectious Diseases submission guide
Lancet Infectious Diseases's submission process, first-decision timing, and the editorial checks that matter before peer review begins.
Associate Professor, Clinical Medicine & Public Health
Author context
Specializes in clinical and epidemiological research publishing, with direct experience preparing manuscripts for NEJM, JAMA, BMJ, and The Lancet.
Readiness scan
Before you submit to Lancet Infectious Diseases, pressure-test the manuscript.
Run the Free Readiness Scan to catch the issues most likely to stop the paper before peer review.
How to approach Lancet Infectious Diseases
Use the submission guide like a working checklist. The goal is to make fit, package completeness, and cover-letter framing obvious before you open the portal.
Stage | What to check |
|---|---|
1. Scope | Consider a presubmission inquiry |
2. Package | Prepare manuscript to Lancet specifications |
3. Cover letter | Submit through Editorial Manager |
4. Final check | Initial editorial assessment |
Quick answer: how to submit to Lancet Infectious Diseases
Submitting to Lancet Infectious Diseases is not mainly a portal problem. It is a positioning problem. The mechanics are straightforward: choose the right article type, prepare a clinically serious cover letter, upload the manuscript and reporting documents through the Elsevier system, and respond quickly if the editors ask for clarifications. The hard part is proving on page one that the paper matters beyond a narrow pathogen or local cohort. If the manuscript does not show immediate practice, policy, or globally relevant infectious-disease significance, the editors usually decide that before peer review.
For most authors, the practical question is not "can I complete the submission?" It is "does this package look like Lancet Infectious Diseases material before I press submit?" If the answer is unclear, fix the package before entering the portal.
Before you open the submission portal
Use this checklist before you upload anything:
- Make sure the article type is correct. Original research, review, correspondence, and comment pieces are screened very differently.
- Rewrite the title and abstract so the clinical or public-health consequence is visible immediately.
- Make sure reporting guidelines are handled cleanly. Clinical trials, observational studies, and systematic reviews are all judged against expected reporting standards.
- Check whether your patient population, geography, and comparator choices make the paper broadly useful, not just locally interesting.
- Prepare a cover letter that explains why the paper belongs in Lancet Infectious Diseases rather than Clinical Infectious Diseases, Journal of Infectious Diseases, or PLOS Medicine.
- Confirm ethics approvals, registrations, funding disclosures, and competing-interest statements are complete before the upload begins.
If you are still debating journal fit at this stage, the portal is too early. The package should already have a clear editorial story.
Step-by-step submission flow
Step | What you need to do | What usually slows authors down |
|---|---|---|
1. Pick the article type | Match the manuscript to the journal's allowed formats and limits. | Authors force a paper into a format that hides the paper's real value. |
2. Finalize the title, abstract, and cover letter | Treat these as the editorial screen, not admin fields. | The manuscript may be stronger than the abstract, but editors only see what is in front of them first. |
3. Prepare reporting and ethics documents | Upload trial registration, ethics approvals, reporting checklists, and funding disclosures. | Missing trial or ethics context creates immediate friction. |
4. Upload the manuscript package | Submit the main text, figures, tables, supplementary files, and author metadata. | Figure legends, supplement labels, and file naming are often messier than authors realize. |
5. Review the PDF proof and metadata | Check affiliations, abstract text, keywords, and figure order inside the system-generated proof. | Small metadata errors can survive into review and create avoidable admin follow-up. |
6. Submit and monitor editorial queries | Be ready to answer fast if the office requests file or ethics clarification. | Delayed responses make an already selective journal less patient. |
The practical submission principle is simple: the portal should feel like the final administrative step, not the place where the manuscript first becomes submission-ready.
When authors struggle, it is usually because the paper still has one of these unresolved issues:
- the abstract does not make the clinical action or public-health implication explicit
- the methods are defensible, but the comparator or sample makes the inference feel narrow
- the cover letter summarizes the paper without saying why Lancet Infectious Diseases is the right editorial home
- the supplement looks like an archive rather than a curated support package
If any of those are true, do not expect the portal to save the paper.
Common mistakes and avoidable delays
The same submission mistakes show up repeatedly at this journal:
- Authors describe a strong infectious-disease dataset but do not show what the result changes for treatment, prevention, stewardship, or policy.
- The paper is methodologically careful but too local in relevance. A single-center or single-setting study needs a stronger generalizability argument than authors usually think.
- The cover letter talks about novelty in generic terms instead of explaining why the paper matters now.
- Abstract language overreaches the data. At Lancet-level journals, overclaiming is not a stylistic issue. It is a trust issue.
- Figures are technically correct but not editorially persuasive. Editors want to understand the clinical signal quickly.
- Authors wait until upload to discover missing disclosures, registration details, or permissions.
Avoidable delay usually comes from admin sloppiness layered on top of an already borderline fit decision. If the manuscript is a real fit, the journal still expects the package to be exceptionally clean.
What editors and reviewers will notice first
Editors at Lancet Infectious Diseases are effectively asking four questions at the start.
1. Does this paper matter beyond its immediate dataset?
Papers do better when the relevance extends beyond one outbreak, one center, or one narrow implementation setting. The journal does publish highly specific infectious-disease studies, but they still need a broader interpretive consequence.
2. Is the manuscript clinically or policy actionable?
Interesting microbiology or epidemiology is not enough on its own. The paper has to help clinicians, public-health decision-makers, or guideline writers think differently after reading it.
3. Does the package look trustworthy on first pass?
Editors notice when registration, ethics, funding, conflicts, and reporting standards are handled cleanly. They also notice when those pieces are messy. Trust is shaped by the package, not only the data.
4. Is this obviously stronger here than at a slightly less selective competitor?
If the paper would make complete sense at Clinical Infectious Diseases or Journal of Infectious Diseases, the editorial question becomes why Lancet Infectious Diseases should spend review capacity on it. Your cover letter and abstract have to answer that directly.
The best submissions make the fit obvious before the editor has to work for it.
What a strong cover letter needs to say
Most weak cover letters for this journal make two mistakes. They summarize the study and they flatter the journal. Neither helps much. A useful cover letter should do four jobs quickly.
State the clinical or public-health decision changed by the paper
Do not just say the study is novel. Say what a reader would do differently after reading it. For example, does the paper change empiric treatment logic, screening practice, outbreak interpretation, stewardship strategy, or guideline debate?
Explain why the timing matters now
Lancet Infectious Diseases pays attention to urgency, but only when urgency is real. If the paper speaks to an active policy debate, an emerging pathogen issue, antimicrobial resistance pressure, vaccine implementation problem, or globally important diagnostic gap, say that plainly.
Explain why this journal is the right editorial home
The editor already knows the journal is prestigious. What they want to know is why your paper belongs here rather than in a slightly narrower infectious-disease venue. If the answer is not obvious, the submission is vulnerable.
Signal a disciplined package
Mention the article type, study design, reporting framework, registration, and the most important package strengths. That tells the editor the manuscript is organized and submission-ready, not improvised.
If you cannot write a one-paragraph answer to those four questions, the cover letter is revealing a fit problem rather than hiding one.
Submit now or fix first
Use this decision split before you upload.
Submit now if
- the paper has a clear global or cross-setting consequence
- the abstract already states the practical implication without exaggeration
- the figures make the clinical signal understandable quickly
- ethics, registration, reporting checklists, and disclosures are already complete
- the cover letter can clearly justify why this paper belongs in Lancet Infectious Diseases
Fix first if
- you are still debating whether the main result is broad enough for this journal
- the abstract currently sounds more impressive than the actual methods support
- your best figure is still too complex for an editor to interpret fast
- you have not pressure-tested the paper against nearby journals such as Clinical Infectious Diseases or Journal of Infectious Diseases
- the supplement still feels like a document dump rather than a curated support package
The practical benefit of this check is simple. It is much better to spend one more day clarifying fit, abstract, and package quality than to spend weeks recovering from an avoidable editorial rejection.
Jump to key sections
Sources
Final step
Submitting to Lancet Infectious Diseases?
Run the Free Readiness Scan to see score, top issues, and journal-fit signals before you submit.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Need deeper scientific feedback? See Expert Review Options
Where to go next
Start here
Same journal, next question
Supporting reads
Conversion step
Submitting to Lancet Infectious Diseases?
Anthropic Privacy Partner. Zero-retention manuscript processing.